Figure 5
From: Prognostic role of serum p53 antibodies in lung cancer
Survival curves of adenocarcinoma patients with p53Ab-positive or p53Ab-low/negative-serum. Survival curves of patients with adenocarcinoma of the lung with p53Ab-positive-serum (dotted line, n = 10) or p53Ab-low/negative-serum (unbroken line, n = 69). No difference in overall survival was observed between the two groups (p = 0.973).